Relmada Therapeutics
RLMD
RLMD
72 hedge funds and large institutions have $393M invested in Relmada Therapeutics in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $469M → $393M (-$76.4M)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
72
Holding in Top 10
3
Calls
$5.79M
Puts
$11K
Top Buyers
| 1 | +$2.82M | |
| 2 | +$2.29M | |
| 3 | +$2.04M | |
| 4 |
Bank of New York Mellon
New York
|
+$1.7M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.6M |
Top Sellers
| 1 | -$8.95M | |
| 2 | -$2.66M | |
| 3 | -$2.17M | |
| 4 |
Millennium Management
New York
|
-$1.94M |
| 5 |
Morgan Stanley
New York
|
-$1.22M |